LEAP THERAPEUTICS, INC. Quarterly Depreciation in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Leap Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q1 2024.
  • Leap Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $5K, a 25% increase year-over-year.
  • Leap Therapeutics, Inc. annual Depreciation for 2023 was $15K, a 6.25% decline from 2022.
  • Leap Therapeutics, Inc. annual Depreciation for 2022 was $16K, a 44.8% decline from 2021.
  • Leap Therapeutics, Inc. annual Depreciation for 2021 was $29K, a 14.7% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5K +$1K +25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $4K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $4K -$3K -42.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $7K -$3K -30% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $10K -$2K -16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $12K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q1 2018 $12K -$13K -52% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $25K Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.